#United States #Charlotte #franchise #regenerative medicine #QC Kinetix

QC Kinetix Unveils Renewed Franchise Strategy

QC Kinetix has officially reinitiated its national franchise development program, marking a significant turning point following an extensive brand transformation. Known as North America's largest regenerative medicine franchise, the company is positioned for enhanced growth after a successful re-evaluation of its operational strategies.

The recent re-launch aligns with the promising outlook for the regenerative medicine industry, which is projected to surge from $35.85 billion in 2024 to an impressive $169.55 billion by 2034. Recognizing this potential, QC Kinetix aims to accelerate its expansion in lucrative markets after a year dedicated to refining its business model and systems.

A milestone achievement occurred in Q2 2025, which marked the company's first quarter of same-clinic sales growth in five quarters. This accomplishment reflects the positive impact of QC Kinetix's 'QCK 2.0 transformation plan', first introduced in July 2024. The brand reported a notable improvement in average clinic profitability, which soared by over 22 percentage points—from just 2.20% to a significant +24.71%. This increase underscores a successful strategy that centers around the franchisees and their performance.

Mark Montini, CEO of QC Kinetix, emphasizes that prioritizing patient outcomes and enhancing the value for franchise owners continue to be pivotal. He stated, “We made a purposeful decision to pause development a year ago to fortify our foundation, and our recent results validate that choice. By adopting a disciplined approach and concentrating on critical success factors, we have cultivated substantial momentum for our brand. This combination creates an ideal opportunity for renewed growth—six months ahead of our original schedule.”

Key Features of the Transformation

The QCK 2.0 initiative encompasses a comprehensive reengineering of QC Kinetix's business model and support systems for franchise owners. Some of the essential elements of this transformation include:

• - Cultural Alignment: Fostering unity between franchise owners, their teams, and the corporate leadership to create better patient outcomes and enhance business success.
• - Enhanced Operating Model: Improvements aimed at boosting efficiency, clinical performance, and profitability at the unit level.
• - Expanded Support Systems: Providing franchisees with cutting-edge tools and resources to enhance their operational effectiveness.
• - Refocused Service Lines: Aiming to leverage the original service offerings that built the brand's reputation.
• - Strategic Clinic Consolidation: Optimizing market presence and maximizing resource allocation for greater impact.

Growth Strategy and Development Plans

Building on the renewed momentum, QC Kinetix has devised a two-pronged growth strategy:

1. New Franchise Development: The company is on the lookout for 50 new franchise owners and aims to open 120 new clinics over the next two years, through an updated approach that focuses on experienced operators who align with the company's vision and values.
2. Refranchising Opportunities: Transitioning select corporate-owned clinics to franchise operation, which not only creates opportunities for qualified operators but also allows for an enhanced focus on supporting existing franchisees.

Montini remarked, “The hard work of our franchise owners, their teams, and our corporate support staff over the past year has fundamentally transformed our exceptional brand and strengthened our growth foundation. Their dedication places us in a robust position to welcome new owners while retaining our leadership in the regenerative medicine arena.”

QC Kinetix is actively offering franchise opportunities to medical professionals as well as business-minded investors. The investment required for a single clinic ranges from $250,100 to $655,080, while multi-unit investments start at $350,100. Franchisees benefit from comprehensive training, established clinical protocols, and ongoing support to ensure sustained success.

For those interested in learning more about franchise opportunities at QC Kinetix, additional information can be found at qcKinetix.com/franchise.

About QC Kinetix

Founded in 2017 in Charlotte, North Carolina, QC Kinetix has grown to become North America's largest regenerative medicine franchise and has been recognized by Inc. 5000 as one of the fastest-growing private companies in America. QC Kinetix specializes in non-surgical, biologic-based treatments aimed at addressing joint pain, injuries, and various musculoskeletal conditions, leveraging the body's natural healing capabilities. The franchise has expanded significantly since commencing operations in 2020, with over 100 clinics currently servicing communities across the U.S. and plans for 350 nationwide.

The details in this article are for informational purposes only and do not constitute an offer for purchase or a solicitation for a franchise agreement. Actual factors influencing franchise performance may vary significantly among individual locations due to diverse considerations, including market conditions and operator experience.